{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:09:03Z","timestamp":1788754143883,"version":"build-2803163510"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                    <jats:p>In 2015, the Advisory Committee on Immunization Practices recommended that 16- to 23-year-olds may be vaccinated with the serogroup B meningococcal (MenB) vaccine on the basis of individual clinical decision-making (Category B). We assessed the following among US pediatricians and family physicians (FPs): (1) practices regarding MenB vaccine delivery, (2) factors influencing a decision to recommend the MenB vaccine, and (3) factors associated with discussing the MenB vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We surveyed a nationally representative sample of pediatricians and FPs via e-mail and Internet from October 2016 to December 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The response rate was 72% (660 of 916). During routine visits, 51% of pediatricians and 31% of FPs reported always or often discussing MenB vaccine. Among those who discussed often or always, 91% recommended vaccination; among those who never or rarely discussed, 11% recommended. We found that 73% of pediatricians and 41% of FPs currently administered the MenB vaccine. Although many providers reported not knowing about factors influencing recommendation decisions, MenB disease outbreaks (89%), disease incidence (62%), and effectiveness (52%), safety (48%), and duration of protection of MenB vaccine (39%) increased the likelihood of recommendation, whereas the Category B recommendation (45%) decreased likelihood. Those somewhat or not at all aware of the MenB vaccine (risk ratio 0.32 [95% confidence interval 0.25\u20130.41]) and those practicing in a health maintenance organization (0.39 [0.18\u20130.87]) were less likely, whereas those aware of disease outbreaks in their state (1.25 [1.08\u20131.45]) were more likely to discuss MenB vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Primary care physicians have significant gaps in knowledge about MenB disease and the MenB vaccine, and this appears to be a major driver of the decision not to discuss the vaccines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2018-0344","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T03:25:12Z","timestamp":1534735512000},"source":"Crossref","is-referenced-by-count":45,"title":["Adoption of Serogroup B Meningococcal Vaccine Recommendations"],"prefix":"10.1542","volume":"142","author":[{"given":"Allison","family":"Kempe","sequence":"first","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Department of Pediatrics, Anschutz Medical Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy A.","family":"Allison","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Department of Pediatrics, Anschutz Medical Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"MacNeil","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Department of Pediatrics, Anschutz Medical Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Crane","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado and Children\u2019s Hospital Colorado, Aurora, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Beaty","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"Hurley","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Division of General Internal Medicine, Denver Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Brtnikova","sequence":"additional","affiliation":[{"name":"Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine,"},{"name":"Department of Pediatrics, Anschutz Medical Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Lindley","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison P.","family":"Albert","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"issue":"4","key":"2021120921392204200_B1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-0281","article-title":"Multicenter surveillance of invasive meningococcal infections in children.","volume":"118","author":"Kaplan","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"2021120921392204200_B2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2021120921392204200_B3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/cix993","article-title":"Current epidemiology and trends in meningococcal disease-United States, 1996-2015.","volume":"66","author":"MacNeil","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"41","key":"2021120921392204200_B4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.","volume":"64","author":"MacNeil","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120921392204200_B5","unstructured":"Centers for Disease Control and Prevention\n          . Enhanced meningococcal disease surveillance report. 2016. Available at: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf. Accessed April 3, 2018"},{"issue":"22","key":"2021120921392204200_B6","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015.","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120921392204200_B7","unstructured":"Ahmed\u2008F\n          . U.S. Advisory Committee on Immunization Practices (ACIP) handbook for developing evidence-based recommendations, version 1.2. 2013. Available at: https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/downloads\/handbook.pdf. Accessed July 5, 2017"},{"key":"2021120921392204200_B8","unstructured":"American Academy of Family Physicians\n          . Meningococcal disease vaccine. 2016. Available at: https:\/\/www.aafp.org\/patient-care\/public-health\/immunizations\/disease-population\/meningococcal.html. Accessed April 4, 2018"},{"issue":"3","key":"2021120921392204200_B9","doi-asserted-by":"crossref","first-page":"e20161890","DOI":"10.1542\/peds.2016-1890","article-title":"Recommendations for serogroup B meningococcal vaccine for persons 10 years and older.","volume":"138","author":"Committee on Infectious Diseases","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"2021120921392204200_B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0163278707311872","article-title":"Sentinel physician networks as a technique for rapid immunization policy surveys.","volume":"31","author":"Crane","year":"2008","journal-title":"Eval Health Prof"},{"key":"2021120921392204200_B11","volume-title":"Internet, Mail and Mixed-Mode Surveys: The Tailored Design Method","author":"Dillman","year":"2009","edition":"3rd ed."},{"issue":"5","key":"2021120921392204200_B12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3122\/jabfm.16.5.363","article-title":"One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians.","volume":"16","author":"Davis","year":"2003","journal-title":"J Am Board Fam Pract"},{"issue":"6","key":"2021120921392204200_B13","first-page":"587","article-title":"Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization.","volume":"42","author":"Freed","year":"1996","journal-title":"J Fam Pract"},{"issue":"6","key":"2021120921392204200_B14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.110.6.e68","article-title":"Physician perspectives regarding pneumococcal conjugate vaccine.","volume":"110","author":"Schaffer","year":"2002","journal-title":"Pediatrics"},{"issue":"5","key":"2021120921392204200_B15","doi-asserted-by":"crossref","first-page":"e20163484","DOI":"10.1542\/peds.2016-3484","article-title":"Understanding the category B recommendation for serogroup B meningococcal vaccine.","volume":"139","author":"Marshall","year":"2017","journal-title":"Pediatrics"},{"issue":"11","key":"2021120921392204200_B16","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.4161\/hv.25505","article-title":"Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine.","volume":"9","author":"Santolaya","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"2021120921392204200_B17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2021120921392204200_B18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1542\/peds.2009-1710","article-title":"Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages.","volume":"125","author":"Kempe","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"2021120921392204200_B19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-3832","article-title":"Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States.","volume":"124","author":"Kempe","year":"2009","journal-title":"Pediatrics"},{"issue":"5","key":"2021120921392204200_B20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.acap.2017.01.001","article-title":"Physician knowledge and attitudes about hepatitis A and current practices regarding hepatitis A vaccination delivery.","volume":"17","author":"Nelson","year":"2017","journal-title":"Acad Pediatr"},{"issue":"2","key":"2021120921392204200_B21","doi-asserted-by":"crossref","first-page":"e20152488","DOI":"10.1542\/peds.2015-2488","article-title":"Primary care physicians\u2019 perspectives about HPV vaccine.","volume":"137","author":"Allison","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"2021120921392204200_B22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amepre.2011.08.007","article-title":"Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians.","volume":"41","author":"Allison","year":"2011","journal-title":"Am J Prev Med"},{"issue":"5","key":"2021120921392204200_B23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpedi.155.5.566","article-title":"Adolescent immunization practices: a national survey of US physicians.","volume":"155","author":"Schaffer","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2021120921392204200_B24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jadohealth.2008.08.019","article-title":"Adolescent Tdap vaccine use among primary care physicians.","volume":"44","author":"Dempsey","year":"2009","journal-title":"J Adolesc Health"},{"issue":"1","key":"2021120921392204200_B25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3122\/jabfm.18.1.13","article-title":"Barriers to adolescent immunization: a survey of family physicians and pediatricians.","volume":"18","author":"Oster","year":"2005","journal-title":"J Am Board Fam Pract"},{"issue":"2","key":"2021120921392204200_B26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amepre.2006.03.023","article-title":"Physician attitudes and preferences about combined Tdap vaccines for adolescents.","volume":"31","author":"Davis","year":"2006","journal-title":"Am J Prev Med"},{"issue":"1","key":"2021120921392204200_B27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amepre.2012.10.001","article-title":"Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.","volume":"44","author":"O\u2019Leary","year":"2013","journal-title":"Am J Prev Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-0344\/1065315\/peds_20180344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-0344\/1065315\/peds_20180344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:19:13Z","timestamp":1639099153000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/142\/3\/e20180344\/81653\/Adoption-of-Serogroup-B-Meningococcal-Vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-0344","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"article-number":"e20180344"}}